Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul-Sep;6(3):142-6.
doi: 10.4103/0976-500X.162022.

Effectiveness of vitamin D3 in severe persistent asthmatic patients: A double blind, randomized, clinical study

Affiliations

Effectiveness of vitamin D3 in severe persistent asthmatic patients: A double blind, randomized, clinical study

Muhasaparur Ganesan Rajanandh et al. J Pharmacol Pharmacother. 2015 Jul-Sep.

Abstract

Objective: To assess the pulmonary function and quality of life in asthma patients receiving vitamin D3 supplementation with inhaled budesonide and formoterol.

Materials and methods: This was a double blinded, randomized, comparative study. Patients were recruited as per the study criteria and randomized into two groups: usual care group (n = 69) patients received budesonide (800 μg) with formoterol (24 μg) and intervention care group (n = 72) patients received vitamin D3 (1000 IU) supplementation along with budesonide (800 μg) plus formoterol (24 μg) for a period of 6 months.

Results: A total of 140 patients completed the study. Significant within-group improvement and non-significant between-group improvement is observed with respect to FEV1. In terms of health-related quality of life, within-group comparison revealed a significant (P < 0.05) improvement in all the domains of SGRQ. However, between-group comparisons showed statistically significant (P < 0.05) improvement in symptom, impact and total scores.

Conclusion: On the basis of our findings, we conclude that supplementation of vitamin D3 is effective in improving the quality of life rather than pulmonary function in severe asthmatics. However, further studies are warranted to substantiate the present findings.

Keywords: Asthma; FEV1; budesonide; formoterol; vitamin D3.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow of patients and CONSORT diagram
Figure 2
Figure 2
Visit-wise change in FEV1 within the study groups
Figure 3
Figure 3
Visit-wise change in SGRQ scores within the study groups

References

    1. Banerjee A, Damera G, Bhandare R, Gu S, Lopez-Boado Y, Panettieri R, Jr, et al. Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells. Br J Pharmacol. 2008;155:84–92. - PMC - PubMed
    1. Viswanathan R, Prasad M, Thakur AK, Sinha SP, Prakash N, Mody RK, et al. Epidemiology of asthma in an urban population. A random morbidity survey. J Indian Med Assoc. 1966;46:480–3. - PubMed
    1. Clifford RL, Knox AJ. Vitamin D - A new treatment for airway remodelling in asthma. Br J Pharmacol. 2009;158:1426–8. - PMC - PubMed
    1. Urry Z, Chambers ES, Xystrakis E, Dimeloe S, Richards DF, Gabryšová L, et al. The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+and IL-10+CD4+T cells. Eur J Immunol. 2012;42:2697–708. - PMC - PubMed
    1. Gergen PJ, Teach SJ, Mitchell HE, Freishtat RF, Calatroni A, Matsui E, et al. Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescents. Am J Clin Nutr. 2013;97:1228–34. - PMC - PubMed

LinkOut - more resources